Trials / Completed
CompletedNCT01386541
Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers
Investigation of Safety/Tolerability, Pharmacokinetics and Pharmacodynamics After Multiple Ascending Doses of BYK324677 in Healthy Volunteers. A Monocentre, Placebo-controlled, Cross-over, Double-blind, Randomised Trial
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Nycomed · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This monocenter trial is conducted to obtain first data on safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) after multiple ascending doses of BYK324677 in humans. In addition, the trial should provide preliminary information on a possible influence of sex, food intake, and posology (once or twice daily administration of BYK324677) to support the further planning of the drug development programme.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BYK324677 | capsules, administered orally |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2011-09-01
- Completion
- 2011-11-01
- First posted
- 2011-07-01
- Last updated
- 2012-05-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01386541. Inclusion in this directory is not an endorsement.